With scientists studying if new semaglutide weight loss drugs could potentially treat dementia, many have questions about the potential impact of Ozempic and Wegovy on the brain. University of Virginia’s Dr. Heather Ferris joins Being Patient Live Talks to discuss the current research on the impact of semaglutide drugs on brain health. An Associate Professor and endocrinologist at the University of Virginia, she specializes in the care of older adults with diabetes. Ferris’s research lab focuses on understanding how changes in brain cholesterol and insulin signaling can impact cognitive decline and the development of Alzheimer’s disease. Listen to the full talk to learn what we currently know about semaglutide drugs and their impact on the brain. Want to learn more about brain health and diet? Check out our interactive guide: https://www.beingpatient.com/guide-diet-brain-health/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related